Technical Analysis for NPCE - Neuropace, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| BB Squeeze Started | Range Contraction | 0.00% | |
| Fell Below 50 DMA | Bearish | -2.48% | |
| 20 DMA Support | Bullish | -2.48% | |
| Upper Bollinger Band Touch | Strength | -2.48% | |
| 20 DMA Support | Bullish | -9.24% | |
| Crossed Above 50 DMA | Bullish | -9.24% | |
| Up 3 Days in a Row | Strength | -9.24% |
| Alert | Time |
|---|---|
| Possible NR7 | about 19 hours ago |
| 20 DMA Support | about 22 hours ago |
| 60 Minute Opening Range Breakdown | about 22 hours ago |
| Down 1% | about 22 hours ago |
| Up 1% | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Electroencephalography Seizure Brain–Computer Interfacing Neuroprosthetics
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Electroencephalography Seizure Brain–Computer Interfacing Neuroprosthetics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.15 |
| 52 Week Low | 5.45 |
| Average Volume | 59,655 |
| 200-Day Moving Average | 9.94 |
| 50-Day Moving Average | 6.88 |
| 20-Day Moving Average | 6.36 |
| 10-Day Moving Average | 6.30 |
| Average True Range | 0.49 |
| RSI (14) | 45.36 |
| ADX | 15.55 |
| +DI | 18.68 |
| -DI | 18.33 |
| Chandelier Exit (Long, 3 ATRs) | 5.73 |
| Chandelier Exit (Short, 3 ATRs) | 6.92 |
| Upper Bollinger Bands | 6.84 |
| Lower Bollinger Band | 5.88 |
| Percent B (%b) | 0.42 |
| BandWidth | 15.01 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.16 |
| MACD Histogram | 0.0533 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.86 | ||||
| Resistance 3 (R3) | 6.87 | 6.70 | 6.76 | ||
| Resistance 2 (R2) | 6.70 | 6.56 | 6.69 | 6.73 | |
| Resistance 1 (R1) | 6.50 | 6.47 | 6.41 | 6.48 | 6.70 |
| Pivot Point | 6.32 | 6.32 | 6.28 | 6.32 | 6.32 |
| Support 1 (S1) | 6.12 | 6.18 | 6.03 | 6.10 | 5.88 |
| Support 2 (S2) | 5.95 | 6.09 | 5.94 | 5.85 | |
| Support 3 (S3) | 5.74 | 5.95 | 5.82 | ||
| Support 4 (S4) | 5.72 |
